# Gene Therapy

> Gene therapy delivers genetic fixes for inherited and acquired diseases using viral vectors and genome editing. It recruits molecular biologists and bioengineers from academia and frequently licenses university-developed editing and delivery technologies.

*Source: [https://selltoscientists.com/industries/gene-therapy/](https://selltoscientists.com/industries/gene-therapy/)*

**Market size:** $95B
**Target researcher profile:** Molecular biologists and bioengineers in viral vectors, genome editing, delivery, and translational medicine

## Use cases

- AAV vector-engineering R&D hiring
- CRISPR delivery partnerships
- University gene-therapy-lab spin-outs
- GMP and translational talent pipeline
- Rare-disease research collaborations

## Representative companies

- Spark Therapeutics
- Sarepta Therapeutics
- BioMarin
- uniQure
- Sangamo Therapeutics
- Intellia Therapeutics
- Beam Therapeutics
- Editas Medicine
- Krystal Biotech
- Solid Biosciences

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product